Fortress Biotech Stock Analysis

FBIO Stock  USD 1.93  0.02  1.05%   
Fortress Biotech is undervalued with Real Value of 3.93 and Target Price of 10.0. The main objective of Fortress Biotech stock analysis is to determine its intrinsic value, which is an estimate of what Fortress Biotech is worth, separate from its market price. There are two main types of Fortress Biotech's stock analysis: fundamental analysis and technical analysis.
The Fortress Biotech stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Fortress Biotech is usually not traded on National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Fortress Stock trading window is adjusted to America/New York timezone.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.

Fortress Stock Analysis Notes

About 21.0% of the company shares are held by company insiders. The book value of Fortress Biotech was currently reported as 0.75. The company recorded a loss per share of 2.13. Fortress Biotech had not issued any dividends in recent years. The entity had 1:15 split on the 10th of October 2023. Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people. To learn more about Fortress Biotech call Lindsay Rosenwald at 781 652 4500 or check out https://www.fortressbiotech.com.

Fortress Biotech Investment Alerts

Fortress Biotech may become a speculative penny stock
Fortress Biotech appears to be risky and price may revert if volatility continues
Fortress Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 57.67 M. Net Loss for the year was (120.86 M) with profit before overhead, payroll, taxes, and interest of 2.14 M.
Fortress Biotech currently holds about 208.35 M in cash with (80.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92.
Fortress Biotech has a very weak financial position based on the latest SEC disclosures
Roughly 21.0% of the company shares are held by company insiders
Latest headline from australianmining.com.au: A WIN for Aurics Munda gold project

Fortress Biotech Upcoming and Recent Events

Earnings reports are used by Fortress Biotech to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Fortress Largest EPS Surprises

Earnings surprises can significantly impact Fortress Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-08-10
2015-06-30-0.14-0.120.0214 
2022-08-11
2022-06-30-0.21-0.24-0.0314 
2020-05-11
2020-03-31-0.23-0.190.0417 
View All Earnings Estimates

Fortress Stock Institutional Investors

Shares
Acadian Asset Management Llc2025-03-31
90.5 K
180 Wealth Advisors, Llc2025-03-31
87.5 K
Commonwealth Equity Services Inc2025-03-31
61.5 K
Integrated Wealth Concepts Llc2025-03-31
59.4 K
Cetera Investment Advisers2025-03-31
46.6 K
Weaver Consulting Group2025-03-31
46.4 K
Pfg Investments, Llc2025-03-31
45.3 K
Group One Trading, Lp2025-03-31
44.8 K
Two Sigma Investments Llc2025-03-31
44.8 K
Cambridge Invest Research Advisors, Inc.2025-03-31
M
Vanguard Group Inc2025-03-31
752.6 K
Note, although Fortress Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Fortress Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 56.48 M.

Fortress Profitablity

The company has Profit Margin (PM) of (0.71) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.7) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.7.

Management Efficiency

Fortress Biotech has return on total asset (ROA) of (0.3237) % which means that it has lost $0.3237 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.4625) %, meaning that it created substantial loss on money invested by shareholders. Fortress Biotech's management efficiency ratios could be used to measure how well Fortress Biotech manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Fortress Biotech's Total Assets are very stable compared to the past year. As of the 9th of July 2025, Non Currrent Assets Other is likely to grow to about 9.4 M, while Non Current Assets Total are likely to drop about 40.2 M.
The operational strategies employed by Fortress Biotech management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Operating Margin
(1.70)
Profit Margin
(0.71)
Beta
1.772
Return On Assets
(0.32)
Return On Equity
(7.46)

Technical Drivers

As of the 9th of July, Fortress Biotech shows the Mean Deviation of 2.64, coefficient of variation of 988.1, and Downside Deviation of 3.0. Fortress Biotech technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Fortress Biotech Price Movement Analysis

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Fortress Biotech price series with the more recent values given greater weights.

Fortress Biotech Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Fortress Biotech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Fortress Biotech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Fortress Biotech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
David Jin over two months ago
Acquisition by David Jin of 5000 shares of Fortress Biotech at 1.2155 subject to Rule 16b-3
 
Lu Lucy over three months ago
Acquisition by Lu Lucy of 49383 shares of Fortress Biotech subject to Rule 16b-3
 
Lindsay Rosenwald over three months ago
Acquisition by Lindsay Rosenwald of 8133 shares of Fortress Biotech subject to Rule 16b-3
 
Lu Lucy over three months ago
Acquisition by Lu Lucy of 30000 shares of Fortress Biotech subject to Rule 16b-3
 
Lindsay Rosenwald over six months ago
Acquisition by Lindsay Rosenwald of 454153 shares of Fortress Biotech subject to Rule 16b-3
 
Rowinsky Eric K over six months ago
Disposition of 8000 shares by Rowinsky Eric K of Fortress Biotech at 4.31 subject to Rule 16b-3
 
Lindsay Rosenwald over six months ago
Acquisition by Lindsay Rosenwald of 1567515 shares of Fortress Biotech at 1.7 subject to Rule 16b-3
 
Lindsay Rosenwald over six months ago
Acquisition by Lindsay Rosenwald of 5000 shares of Fortress Biotech at 7.3942 subject to Rule 16b-3
 
Lindsay Rosenwald over a year ago
Acquisition by Lindsay Rosenwald of 20000 shares of Fortress Biotech at 1.6362 subject to Rule 16b-3
 
David Jin over a year ago
Acquisition by David Jin of 5000 shares of Fortress Biotech at 0.56 subject to Rule 16b-3
 
David Jin over a year ago
Disposition of tradable shares by David Jin of Fortress Biotech subject to Rule 16b-3
 
Lindsay Rosenwald over a year ago
Acquisition by Lindsay Rosenwald of 100000 shares of Fortress Biotech at 0.695 subject to Rule 16b-3

Fortress Biotech Outstanding Bonds

Fortress Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fortress Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fortress bonds can be classified according to their maturity, which is the date when Fortress Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Fortress Biotech Predictive Daily Indicators

Fortress Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Fortress Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Fortress Biotech Forecast Models

Fortress Biotech's time-series forecasting models are one of many Fortress Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Fortress Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Fortress Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Fortress Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Fortress shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Fortress Biotech. By using and applying Fortress Stock analysis, traders can create a robust methodology for identifying Fortress entry and exit points for their positions.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people.

Current Fortress Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Fortress analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Fortress analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
10.0Strong Buy2Odds
Fortress Biotech current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Fortress analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Fortress stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Fortress Biotech, talking to its executives and customers, or listening to Fortress conference calls.
Fortress Analyst Advice Details

Fortress Stock Analysis Indicators

Fortress Biotech stock analysis indicators help investors evaluate how Fortress Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Fortress Biotech shares will generate the highest return on investment. By understating and applying Fortress Biotech stock analysis, traders can identify Fortress Biotech position entry and exit signals to maximize returns.
Begin Period Cash Flow83.4 M
Long Term Debt58 M
Common Stock Shares Outstanding20.8 M
Total Stockholder Equity22.7 M
Tax Provision312 K
Property Plant And Equipment Net17.1 M
Cash And Short Term Investments57.3 M
Cash57.3 M
Accounts Payable31.6 M
Net Debt18.7 M
50 Day M A1.8138
Total Current Liabilities71.4 M
Other Operating Expenses168.1 M
Non Current Assets Total53.9 M
Non Currrent Assets Other4.9 M
Stock Based Compensation32.6 M
When determining whether Fortress Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fortress Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fortress Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fortress Biotech Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.13)
Revenue Per Share
2.501
Quarterly Revenue Growth
0.008
Return On Assets
(0.32)
Return On Equity
(7.46)
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.